| 5.48 Data as of May 20 |  -0.09 / -1.62%Today’s Change | 3.95 Today|||52-Week Range 9.28 | +30.17% Year-to-Date |
| Previous close | 5.57 |
| Today’s open | 5.53 |
| Day’s range | -- - -- |
| Volume | 492,018 |
| Average volume (3 months) | 645,385 |
| Market cap | $309.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -133.93% |
| Earnings growth (this year) | +58.30% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +9,362.90% |
| P/E ratio | 14.8 |
| Price/Sales | 38.91 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| VICLVical Inc | +0.02 | +0.56% |
| RPRXRepros Therapeutics ... | -0.95 | -5.70% |
| NAVBNavidea Biopharmaceu... | +0.06 | +2.51% |
| CNDOCoronado Biosciences... | +0.29 | +2.93% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $5.9M |
| Annual profit (last year) | -$71.1M |
| Net profit margin | -1,212.46% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Harold E. Selick, PhD |
VP-Finance, Controller & Head-Investor Relations Joel A. Fernandes, CPA |
Corporate headquarters South San Francisco, California |
.
